duloxetine hydrochloride has been researched along with Diffuse Myofascial Pain Syndrome in 115 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (23.48) | 29.6817 |
| 2010's | 69 (60.00) | 24.3611 |
| 2020's | 19 (16.52) | 2.80 |
| Authors | Studies |
|---|---|
| Colarossi, G; Eschweiler, J; Knobe, M; Maffulli, N; Migliorini, F; Tingart, M | 1 |
| Alberti, FF; Becker, MW; Blatt, CR; da Silva Dal Pizzol, T; Pilger, D; Ziegelmann, PK | 1 |
| Ahmed, S; Basu, A; Mehta, P | 1 |
| Bidari, A; Gharibpoor, F; Ghavidel-Parsa, B | 1 |
| Doucette, JA; Eguale, T; Farag, HM; Goswami, H; Sultan, I; Yunusa, I | 1 |
| Aster, HC; Braun, A; Evdokimov, D; Sommer, C; Üçeyler, N | 1 |
| Demirel, K; Ocak, H; Tüten, B; Yalçınkaya, B; Yazar, B | 1 |
| Dang, L; Vandal, C; Winslow, BT | 1 |
| Beci, G; Cipolletta, E; Di Carlo, M; Salaffi, F | 1 |
| Di Carlo, M; Farah, S; Salaffi, F; Sarzi-Puttini, P | 1 |
| Baroncini, A; Bell, A; Colarossi, G; Eschweiler, J; Maffulli, N; Migliorini, F | 1 |
| Ege, F; Isik, R | 1 |
| Akintoye, S; Kulkarni, R | 1 |
| Flynn, D | 1 |
| de Assis, MR; Dos Santos Paiva, E; Helfenstein, M; Heymann, RE; Martinez, JE; Pollak, DF; Provenza, JR; Ranzolin, A; Rezende, MC; Ribeiro, LS; Souza, EJR | 1 |
| Amador, TA; da Silva Dal Pizzol, T; de Farias, ÁD; Eberle, L | 1 |
| Loo, JL; Ohn, KM; Ohn, MH | 1 |
| Atencio, MR; Bruti, G; D'Urso, A; Di Giacomo, P; Di Paolo, C | 1 |
| Bidari, A; Gharibpoor, F; Ghavidel-Parsa, B; Khosousi, MJ; Rahimi, A | 1 |
| Aguado, J; D'Amico, F; Feliu-Soler, A; García-Campayo, J; Knapp, M; Luciano, JV; McCracken, LM; Peñarrubia-María, MT; Serrano-Blanco, A | 1 |
| Jo, A; Marlow, NM; Short, EB; Simpson, KN; Vaughn, IA; Zoller, JS | 1 |
| Alten, R; Bär, KJ; Bernateck, M; Brückle, W; Friedel, E; Häuser, W; Henningsen, P; Petzke, F; Sommer, C; Tölle, T; Üçeyler, N; Winkelmann, A | 1 |
| Bondon-Guitton, E; Chenaf, C; Drici, M; Gicquel, C; Gouraud, A; Montastruc, F; Montastruc, JL; Moulis, F | 1 |
| Arora, N; Gupta, A; Reddy, SB | 1 |
| Bernardy, K; Häuser, W; Klose, P; Welsch, P | 1 |
| Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ | 1 |
| Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P | 1 |
| Funatsu, Y; Furutani, M; Kiso, T; Matsuda, R; Moriyama, A | 1 |
| Desai, R; Jo, A; Marlow, NM | 1 |
| Reisli, R; Tuncer Uzun, S; Türk, Ş; Üstün, D; Yılmaz, R | 1 |
| Fusco, ML; Gentile, S | 1 |
| Bidari, A; Ghavidel-Parsa, B; Hassankhani, A; Hosseini, S; Moazen-Zadeh, E; Rahmani, S | 1 |
| Alaka, K; Arnold, LM; Mehta, R; Qiao, M; Upadhyaya, HP; Williams, D | 1 |
| Häuser, W; Tort, S; Uçeyler, N; Urrútia, G; Walitt, B | 1 |
| Andrews, JS; Faries, DE; Novick, D; Peng, X; Sun, P; Sun, S; Wohlreich, MM; Wu, A | 1 |
| Amital, D; Amital, H; Arnson, Y; Milstein, R | 1 |
| Cai, N; Moore, RA; Skljarevski, V; Tölle, TR | 1 |
| Kim, SC; Landon, JE; Solomon, DH | 1 |
| Aguado, J; Alda, M; Garcia-Campayo, J; Gili, M; Guallar, JA; López-Del-Hoyo, Y; Luciano, JV; Magallón, R; Olivan, B; Serrano-Blanco, A | 1 |
| Hughes, RA; Lunn, MP; Wiffen, PJ | 2 |
| Cappelleri, JC; Chu, BC; Johnson, BH; Johnston, SS; Shrady, G; Silverman, SL; Udall, M | 1 |
| Engel, CC | 1 |
| Huelin, R; Khankhel, Z; Mould, J; Parker, L; Wasiak, R | 1 |
| Cerdà-Lafont, M; Cuesta-Vargas, AI; D'Amico, F; García-Campayo, J; Knapp, M; Luciano, JV; Peñarrubia-María, MT; Serrano-Blanco, A | 1 |
| Cappelleri, JC; Clair, AG; Cook, JP; Eisenberg, DF; Gu, T; Masters, ET; Placzek, HE; Wasser, TE | 1 |
| Choy, EH; Deberdt, W; Lipkovich, IA; Sagman, D; Van Wambeke, P | 1 |
| Kim, SC; Landon, JE; Lee, YC | 1 |
| Barulli, L; Chiumarulo, P; Ianieri, G; Marvulli, R; Mastromauro, L; Megna, G; Megna, M; Romanelli, E | 1 |
| Amoako, AO; Brown, C; Riley, T | 1 |
| Alev, L; Mizuno, H; Murakami, M; Nishioka, K; Ochiai, T; Osada, K | 1 |
| Chaparro, LE; DuMerton-Shore, D; Gilron, I; Holden, RR; Milev, R; Towheed, T; Tu, D; Walker, S | 1 |
| Lee, YH; Song, GG | 1 |
| Alev, L; Ichibayashi, H; Ishida, M; Mizuno, H; Murakami, M; Nishioka, K; Ochiai, T; Osada, K | 1 |
| Alev, L; Konno, S; Ochiai, T; Oda, N | 1 |
| Abd El Fattah, MA; Kenawy, SA; Radwan, RR; Shabaan, EA; Shibrya, EE | 1 |
| Alvarenga, R; Manhães, A; Schmidt, G; Schmidt, S | 1 |
| Derry, S; Gaskell, H; Moore, RA; Sultan, A | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Genth, E; Harten, P | 1 |
| Sipkoff, M | 1 |
| de Tommaso, M; Ranieri, M; Sardaro, M; Serpino, C; Stasi, M; Vecchio, E | 1 |
| Acuna, C | 1 |
| Chappell, AS; Detke, MJ; Kajdasz, DK; Mease, PJ; Russell, IJ; Walker, DJ; Wiltse, CG; Wohlreich, MM | 1 |
| Alda, M; Andrés, E; del Hoyo, YL; García-Campayo, J; Luciano, JV; Magallón, R; Rodero, B; Serrano-Blanco, A | 1 |
| Chappell, AS; D'Souza, DN; Kajdasz, DK; Littlejohn, G; Moldofsky, H; Scheinberg, M | 1 |
| Chappell, AS; Choy, EH; Crits-Christoph, P; Kajdasz, DK; Mease, PJ; Walker, DJ; Wohlreich, MM | 1 |
| Curran, MP | 1 |
| Chappell, A; Farrar, JT; Prakash, A; Pritchett, YL; Robinson, M | 1 |
| Rao, SG | 1 |
| Ahl, J; Arnold, LM; Bradley, LA; Choy, EH; Hudson, JI; Mease, PJ; Wang, F; Wohlreich, MM | 1 |
| Staud, R | 1 |
| Briley, M | 1 |
| Bowrin, K; Choy, E; Lloyd, A; Richards, S; Sadosky, A; Watson, P; Zlateva, G | 1 |
| Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J | 1 |
| Häuser, W; Petzke, F; Sommer, C | 1 |
| Bradley, L; Choy, E; Clauw, DJ; Marangell, LB; Mease, P; Shoemaker, S; Wang, F; Wohlreich, MM | 1 |
| Bennett, R; Bradley, LA; Chappell, AS; D'Souza, DN; Moldofsky, H; Russell, IJ; Wang, F; Wohlreich, MM | 1 |
| Jones, KD; Mist, SD; Ross, RL; Wright, CL | 1 |
| Ahl, J; Arnold, LM; Clauw, D; Gaynor, PJ; Wang, F; Wohlreich, MM | 1 |
| Grembiale, RD; Pipicelli, G; Ursini, F | 1 |
| Häuser, W; Petzke, F; Sommer, C; Üçeyler, N | 1 |
| Arnold, LM; Bradley, LA; Chappell, AS; Clauw, DJ; Kajdasz, DK; Mease, PJ; Russell, IJ; Spaeth, M; Walker, DJ | 1 |
| Duenas, H; Gaynor, P; McCarberg, B; Shoemaker, S; Zheng, W | 1 |
| Boulanger, L; Chen, S; Rao, P; Wu, N; Zhao, Y | 1 |
| Burke, JP; Cappelleri, JC; Halpern, R; Joshi, AV; Kulakodlu, M; Sanchez, RJ | 1 |
| Ang, D; Beard, SM; Coleman, A; Lawson, K; Le, TK; Roskell, N; Zhao, Y | 1 |
| Ahl, J; Arnold, LM; Gaynor, PJ; Wang, F; Wohlreich, MM | 1 |
| Thiessen, CN; Traynor, AP; Traynor, LM | 1 |
| Arnold, LM; Gaynor, PJ; Heinloth, AN; Ruberg, SJ; Wang, F | 1 |
| Sun, P; Watson, P; Zhao, Y; Zhao, Z | 1 |
| Bernauer, MJ; Boulanger, L; Chen, SY; Fraser, K; Nagar, S; Wu, N; Zhao, Y; Zhao, Z | 1 |
| Arora, V; Chopra, K; Kuhad, A | 1 |
| Chandran, A; Gore, M; Leslie, D; Tai, KS; Zlateva, G | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Rizzi, M; Sarzi-Puttini, P; Spaeth, M | 1 |
| Bennett, R; Chappell, A; Choy, E; Kajdasz, D; Mease, P; Russell, IJ; Spaeth, M; Walker, D; Wang, F | 1 |
| Langley, P; Nalamachu, S; Pergolizzi, JV; Raffa, RB; Rodriguez, G; Taylor, R | 1 |
| Alten, R; Bär, KJ; Häuser, W; Petzke, F; Sommer, C; Späth, M; Tölle, T; Uçeyler, N; Winkelmann, A; Winter, E | 1 |
| Angeletti, C; Angeletti, PM; Ciccozzi, A; Guetti, C; Marinangeli, F; Paladini, A; Piroli, A; Varrassi, G | 1 |
| Littlejohn, GO | 1 |
| Arnold, LM; Crofford, LJ; Detke, MJ; Goldstein, DJ; Iyengar, S; Lu, Y; Wohlreich, M | 1 |
| Arnold, LM; D'Souza, DN; Goldstein, DJ; Iyengar, S; Pritchett, YL; Rosen, A; Wernicke, JF | 1 |
| Desaiah, D; Perahia, DG; Pritchett, YL; Raskin, J | 1 |
| Gahimer, J; Ossanna, MJ; Viktrup, L; Wernicke, J; Wulster-Radcliffe, M; Yalcin, I | 1 |
| Kajdasz, DK; Lledó, A; Raskin, J; Wang, F; Wernicke, J | 1 |
| Fishbain, DA | 1 |
| Armstrong, DG; Wrobel, JS; Wu, SC | 1 |
| Arnold, LM | 1 |
| Arnold, LM; D'Souza, DN; Iyengar, S; Kajdasz, DK; Pritchett, YL; Wernicke, JF | 1 |
| Price, DD; Staud, R | 1 |
| Arnold, LM; Chappell, AS; Detke, MJ; Kajdasz, DK; Mease, PJ; Russell, JI; Smith, TR; Walker, DJ; Wohlreich, MM | 1 |
| Han, C; Marks, DC; Masand, PS; Pae, CU; Patkar, AA | 1 |
42 review(s) available for duloxetine hydrochloride and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Gabapentin; Humans; Network Meta-Analysis; Pregabalin | 2022 |
Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
Topics: Adolescent; Adult; Amitriptyline; Child; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Network Meta-Analysis; Pain; Pregabalin; Randomized Controlled Trials as Topic | 2022 |
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
Topics: Amitriptyline; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Network Meta-Analysis; Pain; Pregabalin; United States; United States Food and Drug Administration | 2022 |
Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis.
Topics: Adult; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2023 |
A Patient with a History of Fibromyalgia Reports for an Intraoral Incisional Biopsy.
Topics: Biopsy; Duloxetine Hydrochloride; Fibromyalgia; Humans; Ibuprofen | 2023 |
Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews.
Topics: Amitriptyline; Antidepressive Agents; Duloxetine Hydrochloride; Fibromyalgia; Humans; Syndrome; Systematic Reviews as Topic | 2020 |
[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].
Topics: Amitriptyline; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; Fibromyalgia; Germany; Humans; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Societies, Medical | 2017 |
Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Analgesics; Antidepressive Agents; Databases, Factual; Duloxetine Hydrochloride; Female; Fibromyalgia; Gingival Hemorrhage; Humans; Serotonin and Noradrenaline Reuptake Inhibitors | 2017 |
Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials.
Topics: Adaptation, Psychological; Cognitive Behavioral Therapy; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain Management; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Benzodiazepines; Carisoprodol; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Fluoxetine; Humans; Magnesium; Malates; Melatonin; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Pregabalin; Randomized Controlled Trials as Topic | 2018 |
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Carnitine; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Pregabalin; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome | 2018 |
Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU.
Topics: Anti-Anxiety Agents; Duloxetine Hydrochloride; Europe; Female; Fibromyalgia; Humans; Milnacipran; Pregabalin; Pregnancy; Pregnancy Complications; Risk Assessment; Serotonin and Noradrenaline Reuptake Inhibitors; United States | 2019 |
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Topics: Adrenergic Uptake Inhibitors; Adult; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome; Thiophenes | 2013 |
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Topics: Adult; Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Randomized Controlled Trials as Topic; Thiophenes | 2014 |
A systematic review of pharmacoeconomic studies for pregabalin.
Topics: Amines; Analgesics; Anticonvulsants; Chronic Disease; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Economics, Pharmaceutical; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Health Services; Humans; Neuralgia; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Spain; Sweden; United States | 2015 |
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Analgesics; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Network Meta-Analysis; Pregabalin; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
Topics: Adrenergic Uptake Inhibitors; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2008 |
Central sensitisation phenomena in primary headaches: overview of a preventive therapeutic approach.
Topics: Animals; Duloxetine Hydrochloride; Fibromyalgia; Headache; Humans; Migraine Disorders; Pain; Pain Management; Sleep Deprivation; Thiophenes | 2008 |
Duloxetine for the treatment of fibromyalgia.
Topics: Antidepressive Agents; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Fibromyalgia; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Thiophenes | 2008 |
Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.
Topics: Antidepressive Agents; Duloxetine Hydrochloride; Fibromyalgia; Humans; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2009 |
Duloxetine: in patients with fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials, Phase III as Topic; Duloxetine Hydrochloride; Fibromyalgia; Pain Measurement; Thiophenes; Treatment Outcome | 2009 |
Current progress in the pharmacological therapy of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Clinical Trials as Topic; Cyclopropanes; Drugs, Investigational; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
Duloxetine for treating painful neuropathy or chronic pain.
Topics: Analgesics; Chronic Disease; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Randomized Controlled Trials as Topic; Thiophenes | 2009 |
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Topics: Analgesics; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2010 |
Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine.
Topics: Adult; Affect; Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Measurement; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiophenes | 2011 |
Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.
Topics: Duloxetine Hydrochloride; Fatigue; Fibromyalgia; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
Duloxetine for the treatment of fibromyalgia.
Topics: Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pain Measurement; Thiophenes | 2010 |
Efficacy and safety of duloxetine in fibromyalgia.
Topics: Antidepressive Agents; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; Humans; Thiophenes | 2010 |
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.
Topics: Amitriptyline; Antidepressive Agents; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Thiophenes; Treatment Outcome | 2011 |
Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Topics: Aged; Analgesics; Arthralgia; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Knee Joint; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Pain; Thiophenes; Weight Gain; Weight Loss | 2011 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes | 2011 |
Neoteric pharmacotherapeutic targets in fibromyalgia.
Topics: Animals; Cyclopropanes; Drug Approval; Drug Delivery Systems; Drug Design; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes; United States; United States Food and Drug Administration | 2011 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
Fibromyalgia and sleep.
Topics: Analgesics; Central Nervous System Sensitization; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Physical Therapy Modalities; Polysomnography; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Syndrome; Thiophenes | 2011 |
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis; Thiophenes | 2013 |
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
Topics: Amitriptyline; Analgesics; Analgesics, Opioid; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Germany; Humans; Interdisciplinary Communication; Off-Label Use; Patient Care Team; Pregabalin; Somatoform Disorders; Thiophenes | 2012 |
Balanced treatments for fibromyalgia.
Topics: Biogenic Monoamines; Depression; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neurotransmitter Uptake Inhibitors; Pain Threshold; Thiophenes | 2004 |
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Topics: Analgesics; Antidepressive Agents; Chronic Disease; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Thiophenes; Treatment Outcome | 2006 |
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Topics: Adrenergic Uptake Inhibitors; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urinary Incontinence | 2007 |
Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia.
Topics: Antidepressive Agents; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Quality of Life; Randomized Controlled Trials as Topic; Thiophenes | 2007 |
Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Monoamine Oxidase Inhibitors; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Thiophenes; Treatment Outcome | 2007 |
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
Topics: Adult; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Middle Aged; Neurotransmitter Uptake Inhibitors; Pain Measurement; Placebo Effect; Quality of Life; Severity of Illness Index; Thiophenes; Treatment Outcome; Women's Health | 2007 |
24 trial(s) available for duloxetine hydrochloride and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study.
Topics: Acetylcarnitine; Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pregabalin; Treatment Outcome | 2023 |
Okada Purifying Therapy in combination with duloxetine vs. duloxetine alone in patients with TMD and fibromyalgia: a randomized clinical study.
Topics: Double-Blind Method; Duloxetine Hydrochloride; Fibromyalgia; Humans; Surveys and Questionnaires; Treatment Outcome | 2020 |
No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pharmaceutical Preparations; Pregabalin; Treatment Outcome | 2022 |
Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).
Topics: Acceptance and Commitment Therapy; Adult; Analgesics; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pregabalin; Psychotherapy, Group; Spain | 2017 |
Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Topics: Adult; Chronic Pain; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Medication Adherence; Middle Aged; Pregabalin; Treatment Outcome; Young Adult | 2019 |
Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Topics: Adolescent; Analgesics; Analysis of Variance; Chronic Pain; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Pain Measurement; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors | 2019 |
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
Topics: Antidepressive Agents; Chronic Pain; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fibromyalgia; Humans; Individuality; Low Back Pain; Osteoarthritis; Pain Measurement; Thiophenes; Treatment Outcome | 2014 |
Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Analgesics; Catastrophization; Duloxetine Hydrochloride; Female; Fibromyalgia; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Patient Compliance; Pregabalin; Psychiatric Status Rating Scales; Surveys and Questionnaires; Thiophenes; Treatment Outcome; Young Adult | 2014 |
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
Topics: Adult; Analgesics; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Middle Aged; Pregabalin; Quality of Life; Quality-Adjusted Life Years; Surveys and Questionnaires; Thiophenes; Time Factors; Treatment Outcome; United States; United States Food and Drug Administration | 2014 |
Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients.
Topics: Adult; Analgesics; Cluster Analysis; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Thiophenes | 2014 |
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Topics: Adult; Analgesics; Asian People; Constipation; Disorders of Excessive Somnolence; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Japan; Male; Middle Aged; Nasopharyngitis; Nausea; Outpatients; Pain Measurement; Quality of Life; Treatment Outcome | 2015 |
Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Topics: Adult; Aged; Analgesics; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain Management; Pain Measurement; Pregabalin; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia.
Topics: Adult; Analgesics; Constipation; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Nausea; Treatment Outcome; Weight Gain | 2017 |
Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Japan; Low Back Pain; Male; Middle Aged; Pain Measurement; Placebos; Time Factors; Treatment Outcome; Young Adult | 2016 |
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Topics: Antidepressive Agents; Depression; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Status; Humans; Male; Middle Aged; Pain; Pain Measurement; Thiophenes; Treatment Outcome | 2010 |
Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Middle Aged; Pain; Pain Management; Pain Measurement; Pregabalin; Psychiatric Status Rating Scales; Research Design; Spain; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2009 |
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Comorbidity; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Internationality; Male; Middle Aged; Pain; Pain Measurement; Thiophenes; Treatment Outcome; Young Adult | 2009 |
Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2010 |
Estimation of minimum clinically important difference for pain in fibromyalgia.
Topics: Adult; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Measurement; Severity of Illness Index; Thiophenes | 2011 |
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Motor Activity; Musculoskeletal Pain; Pain Threshold; Patient Satisfaction; Placebos; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2011 |
Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia.
Topics: Adult; Dopamine Uptake Inhibitors; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Measurement; Predictive Value of Tests; Regression Analysis; Thiophenes; Time Factors | 2011 |
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Topics: Comorbidity; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Sex Factors; Thiophenes; Treatment Outcome | 2004 |
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Middle Aged; Pain Measurement; Placebo Effect; Quality of Life; Thiophenes; Treatment Outcome; United States; Women's Health | 2005 |
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Clinical Protocols; Clinical Trials as Topic; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Placebo Effect; Thiophenes; Treatment Outcome | 2008 |
49 other study(ies) available for duloxetine hydrochloride and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort.
Topics: Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Mirtazapine; Retrospective Studies; Serotonin | 2022 |
Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level.
Topics: Brain-Derived Neurotrophic Factor; Duloxetine Hydrochloride; Fibromyalgia; Humans; Nociceptive Pain; Pain Measurement | 2022 |
Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study.
Topics: Acetaminophen; Amitriptyline; Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Dipyrone; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Pregabalin; Selective Serotonin Reuptake Inhibitors | 2022 |
Duloxetine induced tachycardia: A rare side effect.
Topics: Analgesics; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Fibromyalgia; Humans | 2023 |
Fibromyalgia: Diagnosis and Management.
Topics: Analgesics; Chronic Pain; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Pregabalin | 2023 |
Predicting acupuncture efficacy in fibromyalgia: results of a pragmatic open-label study.
Topics: Acupuncture Therapy; Duloxetine Hydrochloride; Fibromyalgia; Humans; Male; Pain; Research Design | 2023 |
A Comparative Assessment of the Inflammatory Markers in Patients with Fibromyalgia under Duloxetine Treatment.
Topics: Blood Platelets; Duloxetine Hydrochloride; Fibromyalgia; Humans; Leukocytes; Neutrophils | 2023 |
Chronic Pain Syndromes: Fibromyalgia.
Topics: Chronic Pain; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Milnacipran; Pregabalin | 2023 |
Treatment data from the Brazilian fibromyalgia registry (EpiFibro).
Topics: Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Brazil; Cohort Studies; Combined Modality Therapy; Cross-Sectional Studies; Drug Therapy, Combination; Duloxetine Hydrochloride; Exercise; Female; Fibromyalgia; Health Education; Humans; Male; Middle Aged; Muscle Stretching Exercises; Pregabalin; Registries | 2020 |
Atraumatic trismus induced by duloxetine: an uncommon presentation of acute dystonia.
Topics: Adult; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Duloxetine Hydrochloride; Dystonia; Female; Fibromyalgia; Humans; Procyclidine; Trismus | 2021 |
Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
Topics: Adolescent; Adult; Aged; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Venlafaxine Hydrochloride | 2018 |
Antinuclear Antibody and Subserology Testing in the Evaluation of Fibromyalgia: A Teachable Moment.
Topics: Adult; Analgesics; Antibodies, Antinuclear; Diagnosis, Differential; Duloxetine Hydrochloride; Exercise Therapy; Fibromyalgia; Humans; Male; Patient Education as Topic; Serologic Tests | 2017 |
Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fibromyalgia; Male; Neurotransmitter Agents; Pregabalin; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn | 2018 |
Risk for Medication Nonadherence Among Medicaid Enrollees With Fibromyalgia: Development of a Validated Risk Prediction Tool.
Topics: Adolescent; Adult; Aged; Cohort Studies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Logistic Models; Male; Medicaid; Medication Adherence; Middle Aged; Pregabalin; Prescription Drugs; Retrospective Studies; Risk Assessment; South Carolina; United States | 2019 |
A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Topics: Diagnosis, Differential; Duloxetine Hydrochloride; Fibromyalgia; Humans; Male; Middle Aged; Serotonin and Noradrenaline Reuptake Inhibitors; Tardive Dyskinesia | 2018 |
Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
Topics: Adolescent; Adult; Cohort Studies; Databases, Factual; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2014 |
Retraumatization eliciting the presentation of fibromyalgia.
Topics: Adult; Analgesics; Antidepressive Agents; Cannabinoids; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pregabalin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Stress, Psychological; Thiophenes; Uterine Rupture | 2013 |
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.
Topics: Amines; Amitriptyline; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Cyclohexanecarboxylic Acids; Disease Progression; Duloxetine Hydrochloride; Female; Fibromyalgia; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Prescription Drugs; Retrospective Studies; Thiophenes; Treatment Outcome | 2013 |
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
Topics: Adult; Analgesics; Cohort Studies; Drug Interactions; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Expenditures; Humans; Male; Middle Aged; Pregabalin; Prevalence; Retrospective Studies; Thiophenes | 2014 |
ACP Journal Club. Review: In neuropathy, fibromyalgia, or chronic pain, duloxetine reduces pain but increases adverse events.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neuralgia; Thiophenes | 2014 |
Prior authorization in the treatment of patients with pDPN and FM.
Topics: Adult; Aged; Analgesics; Cohort Studies; Cost of Illness; Cyclopropanes; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Health Services; Humans; Insurance Claim Review; Insurance, Health; Insurance, Pharmaceutical Services; Longitudinal Studies; Male; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2015 |
Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
Topics: Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Cohort Studies; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Female; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Health Services; Humans; Male; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Pregabalin | 2015 |
Objective Assessment of the Rheological Muscle Property in the Treatment of Fibromyalgia.
Topics: Adult; Analgesics; Duloxetine Hydrochloride; Exercise Therapy; Female; Fibromyalgia; Humans; Middle Aged; Muscle, Skeletal; Rheology; Surveys and Questionnaires; Treatment Outcome | 2015 |
Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia.
Topics: Aged; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Hyponatremia; Inappropriate ADH Syndrome; Serotonin and Noradrenaline Reuptake Inhibitors | 2015 |
Evidences for amelioration of reserpine-induced fibromyalgia in rat by low dose of gamma irradiation and duloxetine.
Topics: Analgesics; Animals; Chemoradiotherapy; Duloxetine Hydrochloride; Fibromyalgia; Gamma Rays; Male; Radiotherapy Dosage; Rats; Rats, Wistar; Reserpine; Treatment Outcome | 2017 |
Attentional performance may help to identify duloxetine responders in chronic pain fibromyalgia patients.
Topics: Adult; Aged; Attention; Chronic Pain; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Middle Aged; Neuropsychological Tests; Pain Measurement; Treatment Outcome | 2017 |
Duloxetine (cymbalta) for fibromyalgia.
Topics: Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2008 |
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Clinical Protocols; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Placebo Effect; Pregabalin; Thiophenes; Treatment Outcome | 2008 |
[Evidence-based recommendations for the treatment of fibromyalgia syndrome].
Topics: Adrenergic Uptake Inhibitors; Analgesics; Antidepressive Agents; Combined Modality Therapy; Consensus Development Conferences as Topic; Cross-Sectional Studies; Duloxetine Hydrochloride; Evidence-Based Medicine; Exercise Therapy; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Practice Guidelines as Topic; Pregabalin; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2010 |
Fibromyalgia coverage uneven despite recent drug approvals.
Topics: Analgesics; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Insurance, Pharmaceutical Services; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sickness Impact Profile; Thiophenes; United States; United States Food and Drug Administration | 2008 |
The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
Topics: Adrenergic Uptake Inhibitors; Aged; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Mathematics; Middle Aged; Outcome Assessment, Health Care; Pain Measurement; Randomized Controlled Trials as Topic; ROC Curve; Severity of Illness Index; Somatoform Disorders; Thiophenes; Treatment Outcome | 2010 |
What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
Topics: Antidepressive Agents; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Thiophenes | 2009 |
Pharmacological treatment of fibromyalgia syndrome: new developments.
Topics: Age Factors; Analgesics, Opioid; Calcium Channel Blockers; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Agonists; Duloxetine Hydrochloride; Exercise; Exercise Therapy; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Pain; Pain Measurement; Pain Threshold; Pregabalin; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Self Care; Thiophenes; Treatment Outcome | 2010 |
Drugs to treat fibromyalgia - the transatlantic difference.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Cyclopropanes; Drug Approval; Duloxetine Hydrochloride; European Union; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Off-Label Use; Pregabalin; Thiophenes; United States; United States Food and Drug Administration | 2010 |
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Topics: Adult; Amines; Amitriptyline; Analgesics; Antidepressive Agents; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Drug Costs; Duloxetine Hydrochloride; Fibromyalgia; Gabapentin; gamma-Aminobutyric Acid; Humans; Markov Chains; Models, Econometric; Pregabalin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Thiophenes; Tramadol; United Kingdom | 2010 |
Management of depression in the presence of pain symptoms.
Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine.
Topics: Adult; Antidepressive Agents; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Humans; Insurance Coverage; Insurance, Health; Male; Middle Aged; Patient Compliance; Retrospective Studies; Thiophenes | 2011 |
Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
Topics: Adolescent; Adult; Aged; Analgesics; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Care Costs; Humans; Insurance Claim Review; Male; Middle Aged; Pregabalin; Thiophenes; Young Adult | 2012 |
Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States.
Topics: Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Contraindications; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Markov Chains; Medication Adherence; Middle Aged; Models, Economic; Quality-Adjusted Life Years; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States | 2011 |
Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Algorithms; Analgesics; Comorbidity; Databases, Factual; Dose-Response Relationship, Drug; Drug Costs; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Male; Medication Adherence; Middle Aged; Practice Patterns, Physicians'; Pregabalin; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Predictors of pain medication selection among patients diagnosed with fibromyalgia.
Topics: Adult; Analgesics; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Cohort Studies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Predictive Value of Tests; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2012 |
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
Topics: Adolescent; Adult; Aged; Analgesics; Comorbidity; Databases, Factual; Drug Therapy; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Health Expenditures; Humans; Male; Middle Aged; Pregabalin; Retrospective Studies; Thiophenes; United States; Young Adult | 2012 |
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Topics: Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2012 |
Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
Topics: Analgesics; Comorbidity; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Middle Aged; Pregabalin; Rheumatic Diseases; Thiophenes | 2013 |
Molecule of the month. Duloxetine hydrochloride.
Topics: Adult; Diabetic Neuropathies; Drug Administration Schedule; Duloxetine Hydrochloride; Fibromyalgia; Humans; Multicenter Studies as Topic; Thiophenes; Time Factors | 2004 |
A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anxiety Disorders; Depressive Disorder, Major; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Thiophenes; United States; Urinary Incontinence, Stress | 2007 |
Duloxetine status.
Topics: Antidepressive Agents; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; Humans; Pain; Thiophenes | 2007 |
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Clinical Protocols; Clinical Trials as Topic; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Placebo Effect; Pregabalin; Thiophenes; Treatment Outcome | 2008 |
Duloxetine: an emerging evidence for fibromyalgia.
Topics: Analgesics; Antidepressive Agents; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes | 2009 |